Skip to search formSkip to main contentSkip to account menu

Thrombolytic Therapy

Known as: Therapies, Fibrinolytic, Therapy, Fibrinolytic, fibrinolytics 
Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.
National Institutes of Health

Related topics

Related topics

7 relations
Assay of fibrinolysisFibrinolysisMechanical ThrombolysisSupportive care

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Acute Coronary Syndromes: Diagnosis and Management, Part II
At the most severe end of the spectrum of acute coronary syndromes is ST-segment elevation myocardial infarction (STEMI), which… 
Highly Cited
1986
Highly Cited
1986
Activation of plasminogen by pro-urokinase. I. Mechanism.
The mechanism of the activation of plasminogen by recombinant pro-urokinase (Rec-pro-UK), obtained by expression of the human pro… 
Highly Cited
1986
Highly Cited
1986
Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.
Coagulation and fibrinolysis were studied in patients with acute myocardial infarction during intravenous infusion of recombinant… 
Review
1983
Review
1983
New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.
Highly Cited
1982
Highly Cited
1982
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
Extrinsic (tissue-type) plasminogen activator (plasminogen activator) was isolated either as a single-chain or as a two-chain… 
Highly Cited
1979
Highly Cited
1979
Secretion of plasminogen activator by bone marrow-derived mononuclear phagocytes and its enhancement by colony-stimulating factor
We have studied the production of plasminogen activator (PA) by mononuclear phagocytes derived from mouse bone marrow precursor… 
Highly Cited
1972
Highly Cited
1972
Differences in the Binding to Fibrin of Urokinase and Tissue Plasminogen Activator
Summary When present during clot formation, tissue plasminogen activator (TA, porcine) is strongly bound to fibrin, in marked… 
Highly Cited
1962
Highly Cited
1962
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown…
A clinical syndrome characterized by hypofibrinogenemia, a coagulation defect, often an associated severe hemorrhagic diathesis… 
Highly Cited
1959
Highly Cited
1959
Studies on enhanced fibrinolytic activity in man.
Over the years there have been reports describing the occurrence of increased fibrinolytic activity in the blood of both humans… 
Highly Cited
1957
Highly Cited
1957
Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)